How To Stay Compliant With U.S. Anti‑Drug Regulations in Paraguay: The 5 Steps
A practical guide for businesses and NGOs to navigate the new U.S. anti‑drug office in Asunción and avoid legal pitfalls.
With the U.S. anti‑drug office now operating in Asunción, businesses in Paraguay face new regulatory scrutiny. Staying compliant isn’t optional—it’s essential to avoid hefty fines and operational disruptions. This guide walks you through five concrete steps to align your operations with U.S. anti‑drug laws in 2026.
Step 1: Map Your Supply Chain to Identify Drug‑Risk Nodes
Start by creating a visual map of every leg of your supply chain using Lucidchart or Microsoft Visio. Highlight any transportation routes that cross borders known for drug trafficking, such as the Paraguay–Brazil corridor. Identify those high‑risk nodes and flag them for additional scrutiny in your compliance plan.
Step 2: Register With the U.S. DEA and File the Required 301 Forms
Visit the Drug Enforcement Administration’s online portal (https://www.dea.gov) to register your entity and submit DEA Form 301 for each controlled‑substance transaction. Use the DEA’s e‑Filing system to track submission status and receive automated confirmations within 48 hours. Complete the registration before your next shipment to avoid shipment delays.
Step 3: Implement a Real‑Time Monitoring System Using Trade‑Compliance Software
Deploy tools like Amber Road or SAP Ariba to monitor shipment data against the U.S. Treasury’s OFAC sanctions list and the U.S. Department of Commerce’s Entity List. Configure alerts for any flagged addresses or carriers. Set daily dashboards that provide instant visibility into potential violations.
Step 4: Engage Local Law Enforcement and the U.S. Counter‑Terrorism Advisor
Schedule quarterly joint inspections with Paraguay’s Dirección Nacional de Control de Drogas (DNCD) and coordinate with the U.S. counter‑terrorism adviser assigned to the Southern Cone. Use the U.S. Embassy’s secure communication channel (https://paraguay.usembassy.gov) to share audit results and receive guidance. Collaborate to conduct joint training sessions on anti‑drug compliance.
Step 5: Conduct an Annual Compliance Audit and Publish a Public Report
Hire an independent auditor like PwC or KPMG to review your compliance program and verify adherence to DEA, OFAC, and local regulations. Summarize findings in a concise report and publish it on your company’s ESG page. Publish the report to demonstrate transparency and reassure investors and partners.
Don’t overlook the importance of employee training—use the U.S. DEA’s free online course “Drug Enforcement Basics” to keep staff up‑to‑date on the latest regulatory changes.
By mapping your supply chain, registering with the DEA, monitoring in real time, collaborating with law enforcement, and reporting annually, you’ll create a resilient compliance framework that protects your business from legal risk. Now you have a clear, actionable roadmap for 2026. Start implementing Step 1 today and stay ahead of regulatory changes.
